Literature DB >> 11641667

Abnormal fetal heart rate tracing patterns during the first stage of labor: effect on perinatal outcome.

A Hadar1, E Sheiner, M Hallak, M Katz, M Mazor, I Shoham-Vardi.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate perinatal outcomes of infants who had pathologic fetal heart rate tracings during the first stage of labor, in comparison with pregnancies with normal tracings. STUDY
DESIGN: The perinatal outcomes of 301 infants born at 37 to 42 weeks of gestation with pathologic fetal heart rate patterns during the first stage of labor were compared with 300 infants with normal fetal heart rate tracing patterns. The data were collected prospectively. Tracings were interpreted with the use of the National Institute of Child Health and Human Development fetal heart rate monitor guidelines.
RESULTS: Hydramnios (odds ratio, 7.68; 95% CI, 1.75%-33.63%), oligohydramnios (odds ratio, 2.74; 95% CI, 1.01%-7.39%), and the presence of meconium-stained amniotic fluid (odds ratio, 1.91; 95% CI, 1.03%-3.3%) were independent factors that were associated with pathologic fetal heart rate monitoring during the first stage of labor in a multivariable analysis. The occurrences of umbilical arterial pH of <7.20, a 1-minute Apgar score of <7, a base deficit of 12 mmol/L or higher, and operative deliveries were significantly higher in the study group as compared with subjects with normal fetal heart rate monitoring. Late decelerations and severe variable decelerations (<70 bpm) during the first stage of labor were independent risk factors (odds ratio, 17.5; 95% CI, 1.61%-185.7% and odds ratio, 3.9; 95% CI, 1.36%-11.7%, respectively) that were associated with fetal acidosis (determined by both pH of <7.2 and a base deficit of 12 mmol/L or higher) in a multiple logistic model, controlled for hydramnios, oligohydramnios, meconium-stained amniotic fluid, augmentation by oxytocin, nulliparity, duration of first stage of labor, and birth weight.
CONCLUSION: The operative delivery rate was higher among patients with abnormal first-stage fetal heart rate patterns. Late decelerations and severe variable decelerations were significant factors associated with fetal acidosis.

Entities:  

Mesh:

Year:  2001        PMID: 11641667     DOI: 10.1067/mob.2001.117359

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Association between type of health insurance and elective cesarean deliveries: New Jersey, 2004-2007.

Authors:  Marco D Huesch
Journal:  Am J Public Health       Date:  2011-09-22       Impact factor: 9.308

2.  Systematic review of Doppler for detecting intrapartum fetal heart abnormalities and measuring perinatal mortality in low- and middle-income countries.

Authors:  Marya Plotkin; Benjamin Kamala; Jim Ricca; Linda Fogarty; Sheena Currie; Hussein Kidanto; Stephanie B Wheeler
Journal:  Int J Gynaecol Obstet       Date:  2019-12-05       Impact factor: 3.561

3.  Intermittent fetal heart rate monitoring using a fetoscope or hand held Doppler in rural Tanzania: a randomized controlled trial.

Authors:  Paschal Francis Mdoe; Hege L Ersdal; Estomih R Mduma; Jeffrey M Perlman; Robert Moshiro; Peter T Wangwe; Hussein Kidanto
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-04       Impact factor: 3.007

4.  Scale-Up of Doppler to Improve Intrapartum Fetal Heart Rate Monitoring in Tanzania: A Qualitative Assessment of National and Regional/District Level Implementation Factors.

Authors:  Marya Plotkin; John George; Felix Bundala; Gaudiosa Tibaijuka; Lusekelo Njonge; Ruth Lemwayi; Mary Drake; Dunstan Bishanga; Barbara Rawlins; Rohit Ramaswamy; Kavita Singh; Stephanie Wheeler
Journal:  Int J Environ Res Public Health       Date:  2020-03-16       Impact factor: 3.390

5.  Proportion and Associated Factors of Nonreassuring Fetal Heart Rate Patterns in Finote Selam Primary Hospital, North West Ethiopia.

Authors:  Eden Asmare Kassahun; Amlaku Mulat Aweke; Almaz Aklilu Getu; Getahun Belay Gela; Simachew Kassa Limenih; Mesafint Ewnetu Mekonnen; Tilksew Ayalew Abtie
Journal:  Biomed Res Int       Date:  2020-09-19       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.